Chabiotech Co Ltd
KOSDAQ:085660
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
10 740
19 870
|
Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Chabiotech Co Ltd
Total Current Liabilities
Chabiotech Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
C
|
Chabiotech Co Ltd
KOSDAQ:085660
|
Total Current Liabilities
â‚©961.8B
|
CAGR 3-Years
40%
|
CAGR 5-Years
32%
|
CAGR 10-Years
32%
|
Chabiotech Co Ltd
Glance View
Cha Biotech Co., Ltd. engages in the research of cell therapy and storage of cord blood. The company is headquartered in Seoul, Seoul. The company went IPO on 2005-12-27. is a Korea-based company mainly engaged in the bio business. Along with its subsidiaries, the Company operates its business through two segments: bio segment and optical segment. Its bio segment engages in the provision of medical services; development of stem cells and cell therapy products; production of cosmetics and cosmetic raw materials; distribution of medical devices and others, as well as cord blood storage, health care services and others. Its optical segment engages in the manufacture of optical lenses, optical modules and other parts, which are used in mobile phone cameras.
See Also
What is Chabiotech Co Ltd's Total Current Liabilities?
Total Current Liabilities
961.8B
KRW
Based on the financial report for Sep 30, 2024, Chabiotech Co Ltd's Total Current Liabilities amounts to 961.8B KRW.
What is Chabiotech Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
32%
Over the last year, the Total Current Liabilities growth was 123%. The average annual Total Current Liabilities growth rates for Chabiotech Co Ltd have been 40% over the past three years , 32% over the past five years , and 32% over the past ten years .